-
Two Years In: New Long-Term Extension Data from PIVOT-HD for Votoplam
Latest News
-
Illuminating findings in blood cells from Huntington's disease patients
Levels of the huntingtin protein can be directly measured in blood – could this be useful for gene silencing studies?
-
Giving Huntington's disease the finger? Two teams report success for zinc-finger drugs in cells and mice
Success in Huntington’s disease cells and mice for zinc finger drugs that reduce production of the harmful protein
-
Start here!
Huntington's disease research news. In plain language. Written by scientists. For the global HD community.
-
HDBuzz Prize winner 2012: Deep brain stimulation for HD
HDBuzz Prizewinner 2012: Deep brain stimulation to treat uncontrollable movements called chorea in Huntington's disea
-
Interview: Alice and Nancy Wexler
HDBuzz interviews Alice and Nancy Wexler, the sisters at the heart of the Hereditary Disease Foundation
-
Video: What’s new in Huntington's disease research 2012
Watch Ed Wild's address to the European Huntington's Association on how HD research works and the most promising poss
-
Shooting the messenger with single-stranded RNA gene silencing
New ‘single-stranded RNA’ gene silencing drugs could be safer & more effective to treat Huntington’s disease
-
EuroBuzz Video: Day 2
Watch the full video of EuroBuzz day 2 with Jeff Carroll and Ed Wild at the Euro-HD Network Meeting in Stockholm
-
EuroBuzz Video: Day 1
Watch the full video of EuroBuzz day 1 with Jeff Carroll and Ed Wild at the Euro-HD Network Meeting in Stockholm
-
EuroBuzz News: Day 3
EuroBuzz news: Day 3. Ed and Jeff reporting from the European Huntington’s Disease Network 2012 meeting in Stockholm
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
REGEN4HD, Phase 1 stem cell implantation study commences
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
